Ginkgo Bioworks Holdings, Inc. (DNA) Balance Sheet
DNA balance sheet, 2025
December 31, 2025 · U.S. dollars$1.12B assets = $611.1M liabilities + $508.6M equity
Both columns are drawn to the same scale: what DNA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
DNA financial health
Descriptive bands, not a rating. Fiscal 2025.
DNA balance sheet trends, 2019–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $697.3M2019 | $1.12B2025 | +8.2%/yr | |
| Total liabilities | $195.5M2019 | $611.1M2025 | +20.9%/yr | |
| Shareholders’ equity | $493.1M2019 | $508.6M2025 | +0.5%/yr | |
| Cash & short-term investments | $495.3M2019 | $422.6M2025 | −2.6%/yr | |
| Total debt | $17.4M2019 | $439.9M2025 | +71.4%/yr | |
| Net cash (debt) | $477.9M2019 | −$17.3M2025 | −$495.2M | |
| Working capital | $471.9M2019 | $375.9M2025 | −$96.0M | |
| Book value per share | $17.162019 | $9.172025 | −9.9%/yr | |
| Current ratio | 12.772019 | 4.922025 | −7.86 | |
| Debt / equity | 0.042019 | 0.862025 | +0.83 | |
| Shares outstanding | 28.7M2019 | 55.5M2025 | +11.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
DNA assets
DNA liabilities and equity
DNA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
DNA balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & short-term investments | $422.6M | $561.6M | $944.1M | $1.32B | $1.55B | $380.8M | $495.3M |
| Cash & equivalents | $167.2M | $561.6M | $944.1M | $1.32B | $1.55B | $380.8M | $495.3M |
| Short-term investments | $255.4M | $0 | −$654,000 | — | — | — | — |
| Receivables | $24.0M | $22.4M | $17.9M | $84.0M | $149.9M | $21.9M | $7.7M |
| Inventory | $0 | $0 | $46,000 | $4.4M | $3.4M | $9.3M | $0 |
| Other current assets | $25.2M | $18.7M | $39.7M | $45.9M | $19.8M | $14.6M | $9.0M |
| Total current assets | $471.8M | $602.7M | $1.00B | $1.45B | $1.72B | $426.5M | $511.9M |
| Property, plant & equipment (net) | $528.7M | $598.2M | $395.0M | $718.8M | $145.8M | $121.4M | $63.1M |
| Goodwill & intangible assets | $56.9M | $72.5M | $132.0M | $171.3M | $43.0M | $5.2M | $5.7M |
| Long-term investments | $14.9M | $48.5M | $77.9M | $113.7M | $102.0M | $103.1M | $0 |
| Other non-current assets | $47.4M | $55.6M | $58.7M | $85.5M | $57.2M | $18.9M | $116.6M |
| Total assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675.2M | $697.3M |
| Liabilities | |||||||
| Accounts payable | $10.6M | $14.2M | $9.3M | $10.5M | $8.2M | $13.9M | $2.4M |
| Short-term debt | $22.8M | $29.0M | $17.5M | $29.3M | $747,000 | $485,000 | $598,000 |
| Deferred revenue | $20.0M | $30.6M | $48.5M | $47.8M | $33.2M | $28.8M | — |
| Total current liabilities | $96.0M | $107.3M | $163.9M | $173.0M | $134.8M | $73.2M | $40.1M |
| Long-term debt | $0 | $26,000 | $481,000 | $0 | $22.3M | $16.5M | $16.8M |
| Lease obligations | $439.9M | $467.7M | $241.8M | $413.3M | $23.0M | $17.0M | — |
| Other long-term liabilities | $515.1M | $554.1M | $403.8M | $630.1M | $346.6M | $115.4M | $138.6M |
| Total liabilities | $611.1M | $661.4M | $568.2M | $803.0M | $503.6M | $205.1M | $195.5M |
| Shareholders' equity | |||||||
| Common stock & paid-in capital | $6,000 | $5,000 | $5,000 | $190,000 | $161,000 | $129,000 | $79,000 |
| Retained earnings (deficit) | −$6.15B | −$5.84B | −$5.29B | −$4.40B | −$2.30B | −$467.9M | −$341.3M |
| Accumulated other comprehensive income | $1.9M | −$1.8M | $1.5M | −$2.6M | −$1.7M | $0 | — |
| Minority interest | — | $0 | $0 | $0 | $62.0M | — | — |
| Total shareholders' equity | $508.6M | $716.1M | $1.10B | $1.74B | $1.51B | $461.4M | $493.1M |
| Key figures | |||||||
| Total debt | $439.9M | $467.7M | $239.3M | $442.6M | $23.0M | $17.0M | $17.4M |
| Net cash (debt) | −$17.3M | $93.8M | $704.8M | $873.2M | $1.53B | $363.8M | $477.9M |
| Working capital | $375.9M | $495.5M | $837.9M | $1.28B | $1.59B | $353.3M | $471.9M |
| Tangible book value | $451.7M | $643.5M | $965.2M | $1.57B | $1.46B | $456.2M | $487.4M |
| Book value per share | $9.17 | $13.80 | $22.57 | $41.34 | $44.26 | $14.48 | $17.16 |
| Shares outstanding | 55.5M | 51.9M | 48.6M | 42.0M | 34.0M | 31.9M | 28.7M |
| Current ratio | 4.92 | 5.62 | 6.11 | 8.38 | 12.79 | 5.83 | 12.77 |
| Quick ratio | 4.65 | 5.44 | 5.87 | 8.09 | 12.61 | 5.50 | 12.55 |
| Debt / equity | 0.86 | 0.65 | 0.22 | 0.25 | 0.02 | 0.04 | 0.04 |
| Equity / assets | 45.4% | 52.0% | 65.9% | 68.4% | 72.7% | 68.3% | 70.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $302.2M | $373.5M | $422.6M | $461.9M | $473.7M | $516.9M | $561.6M | $616.2M | $730.4M | $843.8M | $948.9M | $1.05B |
| Cash & equivalents | $84.5M | $143.9M | $167.2M | $111.1M | $203.6M | $312.4M | $561.6M | $616.2M | $730.4M | $843.8M | $944.1M | $1.05B |
| Short-term investments | $217.6M | $229.6M | $255.4M | $350.8M | $270.1M | $204.5M | $0 | — | $57.8M | — | — | −$643,000 |
| Receivables | $13.0M | $19.8M | $24.0M | $21.4M | $23.1M | $27.2M | $22.4M | $23.9M | $18.9M | $24.6M | $17.9M | $63.1M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $46,000 | $70,000 |
| Other current assets | $17.4M | $16.7M | $25.2M | $22.8M | $26.2M | $20.4M | $18.7M | $22.3M | $34.1M | $34.7M | $34.9M | $29.4M |
| Total current assets | $332.5M | $410.0M | $471.8M | $506.1M | $523.0M | $564.5M | $602.7M | $662.5M | $783.4M | $903.0M | $1.00B | $1.14B |
| Property, plant & equipment (net) | $504.8M | $516.8M | $528.7M | $544.8M | $562.1M | $581.2M | $598.2M | $616.9M | $628.6M | $416.8M | $397.2M | $543.2M |
| Goodwill & intangible assets | $44.4M | $48.9M | $56.9M | $61.5M | $66.2M | $68.8M | $72.5M | $79.6M | $90.6M | $125.3M | $132.0M | $158.2M |
| Long-term investments | $22.3M | $14.6M | $14.9M | $29.9M | $32.4M | $32.0M | $48.5M | $61.9M | $62.2M | $75.7M | $77.9M | $85.6M |
| Other non-current assets | $86.0M | $42.8M | $47.4M | $46.9M | $47.2M | $47.0M | $55.6M | $60.0M | $60.5M | $60.9M | $56.5M | $97.5M |
| Total assets | $990.0M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | $1.67B | $2.03B |
| Liabilities | ||||||||||||
| Accounts payable | $9.6M | $16.3M | $10.6M | $10.7M | $11.2M | $11.3M | $14.2M | $15.7M | $23.0M | $27.0M | $9.3M | $10.8M |
| Short-term debt | — | — | $22.8M | $0 | $0 | $0 | $29.0M | $0 | — | — | $19.9M | $0 |
| Deferred revenue | $13.2M | $14.9M | $20.0M | $25.2M | $28.3M | $33.7M | $30.6M | $22.9M | $26.0M | $33.6M | $48.5M | $42.8M |
| Total current liabilities | $72.7M | $79.6M | $96.0M | $115.3M | $96.7M | $115.7M | $107.3M | $114.4M | $166.2M | $169.0M | $163.9M | $168.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $404.1M | $410.7M | $439.9M | $422.9M | $428.8M | $434.6M | $467.7M | $445.6M | $452.3M | $234.5M | $241.8M | $403.7M |
| Other long-term liabilities | $497.0M | $510.3M | $515.1M | $514.1M | $521.3M | $530.4M | $554.1M | $568.5M | $626.0M | $425.4M | $404.3M | $605.2M |
| Total liabilities | $569.8M | $589.9M | $611.1M | $629.4M | $618.1M | $646.0M | $661.4M | $682.9M | $792.2M | $594.5M | $568.2M | $773.7M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $6,000 | $6,000 | $6,000 | $6,000 | $6,000 | $5,000 | $5,000 | $5,000 | $206,000 | $202,000 | $199,000 | $198,000 |
| Retained earnings (deficit) | −$6.28B | −$6.23B | −$6.15B | −$6.07B | −$5.99B | −$5.93B | −$5.84B | −$5.73B | −$5.67B | −$5.46B | −$5.29B | −$5.08B |
| Accumulated other comprehensive income | $950,000 | $1.2M | $1.9M | $2.0M | $1.7M | −$850,000 | −$1.8M | $263,000 | −$1.7M | −$1.6M | $1.5M | −$2.9M |
| Total shareholders' equity | $420.3M | $443.2M | $508.6M | $559.8M | $613.0M | $647.4M | $716.1M | $797.9M | $833.1M | $987.3M | $1.10B | $1.25B |
| Key figures | ||||||||||||
| Total debt | $404.1M | $410.7M | $439.9M | $422.9M | $428.8M | $434.6M | $467.7M | $445.6M | $452.3M | $234.5M | $241.8M | $403.7M |
| Net cash (debt) | −$102.0M | −$37.2M | −$17.3M | $39.0M | $44.9M | $82.4M | $93.8M | $170.6M | $278.1M | $609.3M | $707.1M | $645.6M |
| Working capital | $259.8M | $330.4M | $375.9M | $390.8M | $426.3M | $448.9M | $495.5M | $548.1M | $617.2M | $734.0M | $837.9M | $973.4M |
| Tangible book value | $375.9M | $394.3M | $451.7M | $498.3M | $546.8M | $578.7M | $643.5M | $718.4M | $742.5M | $862.0M | $965.2M | $1.09B |
| Book value per share | $6.77 | $7.44 | $9.17 | $10.06 | $11.17 | $11.94 | $13.80 | $15.27 | $16.22 | $19.75 | $21.93 | $25.69 |
| Shares outstanding | 62.1M | 59.6M | 55.5M | 55.6M | 54.9M | 54.2M | 51.9M | 52.2M | 51.4M | 50.0M | 50.0M | 48.8M |
| Current ratio | 4.57 | 5.15 | 4.92 | 4.39 | 5.41 | 4.88 | 5.62 | 5.79 | 4.71 | 5.34 | 6.11 | 6.78 |
| Quick ratio | 4.33 | 4.94 | 4.65 | 4.19 | 5.14 | 4.70 | 5.44 | 5.59 | 4.51 | 5.14 | 5.90 | 6.60 |
| Debt / equity | 0.96 | 0.93 | 0.86 | 0.76 | 0.70 | 0.67 | 0.65 | 0.56 | 0.54 | 0.24 | 0.22 | 0.32 |
| Equity / assets | 42.5% | 42.9% | 45.4% | 47.1% | 49.8% | 50.1% | 52.0% | 53.9% | 51.3% | 62.4% | 65.9% | 61.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 26, 2026); data from EODHD.
DNA financial position
At the end of fiscal 2025 (December 31, 2025), Ginkgo Bioworks had total assets of $1.1 billion (down 18.7% from a year earlier), total liabilities of $611.1 million and shareholders' equity of $508.6 million. It held $422.6 million in cash and short-term investments against $439.9 million of debt, net debt of $17.3 million. Its current ratio was 4.92. In the latest quarter (ended June 30, 2026) total assets were $990.0 million and equity $420.3 million.
Related: DNA income statement, DNA cash flow statement, DNA key metrics. See the DNA stock overview for the latest quote and news.
DNA balance sheet FAQ
What are Ginkgo Bioworks's total assets?
Ginkgo Bioworks reported total assets of $1.1 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.4 billion a year earlier.
How much debt does Ginkgo Bioworks have?
Ginkgo Bioworks had $439.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.86.
How much cash does Ginkgo Bioworks have?
Ginkgo Bioworks held $422.6 million in cash and short-term investments at the end of fiscal 2025; with $439.9 million of debt that is net debt of $17.3 million.
What is Ginkgo Bioworks's book value?
Ginkgo Bioworks's shareholders' equity (book value) was $508.6 million at the end of fiscal 2025, or $9.17 per share.
What is Ginkgo Bioworks's current ratio?
Ginkgo Bioworks had current assets of $471.8 million and current liabilities of $96.0 million, a current ratio of 4.92 (it can cover its short-term obligations).
How much goodwill does Ginkgo Bioworks have?
Ginkgo Bioworks carried $56.9 million of goodwill and intangible assets, 5.1% of total assets, at the end of fiscal 2025.